PH12015501811A1 - Production of encapsulated nanoparticles at high volume fractions - Google Patents

Production of encapsulated nanoparticles at high volume fractions

Info

Publication number
PH12015501811A1
PH12015501811A1 PH12015501811A PH12015501811A PH12015501811A1 PH 12015501811 A1 PH12015501811 A1 PH 12015501811A1 PH 12015501811 A PH12015501811 A PH 12015501811A PH 12015501811 A PH12015501811 A PH 12015501811A PH 12015501811 A1 PH12015501811 A1 PH 12015501811A1
Authority
PH
Philippines
Prior art keywords
production
high volume
volume fractions
biologically active
encapsulated nanoparticles
Prior art date
Application number
PH12015501811A
Inventor
Aaron Dodd
Felix Meiser
Adrian Russell
Marck Norret
H William Bosch
Original Assignee
Iceutica Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2009901744A external-priority patent/AU2009901744A0/en
Priority claimed from PCT/AU2010/000464 external-priority patent/WO2010121320A1/en
Application filed by Iceutica Pty Ltd filed Critical Iceutica Pty Ltd
Publication of PH12015501811A1 publication Critical patent/PH12015501811A1/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

The present invention relates to methods for producing particles of a biologically active material using dry milling processes as well as compositions comprising such materials, medicaments produced using said biologically active materials in particulate form and/or compositions, and to methods of treatment of an animal, including man, using a therapeutically effective amount of said biologically active materials administered by way of said medicaments.
PH12015501811A 2009-04-24 2015-08-17 Production of encapsulated nanoparticles at high volume fractions PH12015501811A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17227809P 2009-04-24 2009-04-24
AU2009901744A AU2009901744A0 (en) 2009-04-24 Production of Encapsulated Nanoparticles at High Volume Fractions
PCT/AU2010/000464 WO2010121320A1 (en) 2009-04-24 2010-04-23 Production of encapsulated nanoparticles at high volume fractions

Publications (1)

Publication Number Publication Date
PH12015501811A1 true PH12015501811A1 (en) 2019-03-25

Family

ID=66329338

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12015501811A PH12015501811A1 (en) 2009-04-24 2015-08-17 Production of encapsulated nanoparticles at high volume fractions

Country Status (2)

Country Link
HK (2) HK1225958A1 (en)
PH (1) PH12015501811A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006031026A1 (en) * 2004-09-15 2006-03-23 Cj Corp. Method for preparing micron-sized ginseng powder via mechanical grinding
WO2008000042A1 (en) * 2006-06-30 2008-01-03 Iceutica Pty Ltd Methods for the preparation of biologically active compounds in nanoparticulate form
WO2008118331A2 (en) * 2007-03-22 2008-10-02 Schering Corporation Tablet formulations containing 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one salts and tablets made therefrom
US20080254128A1 (en) * 2006-04-28 2008-10-16 Dimitrios Zarkadas Process for the precipitation and isolation of 6,6-dimethyl-3-aza-bicyclo [3.1.0] hexane-amide compounds by controlled precipitation and pharmaceutical formulations containing same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006031026A1 (en) * 2004-09-15 2006-03-23 Cj Corp. Method for preparing micron-sized ginseng powder via mechanical grinding
US20080254128A1 (en) * 2006-04-28 2008-10-16 Dimitrios Zarkadas Process for the precipitation and isolation of 6,6-dimethyl-3-aza-bicyclo [3.1.0] hexane-amide compounds by controlled precipitation and pharmaceutical formulations containing same
WO2008000042A1 (en) * 2006-06-30 2008-01-03 Iceutica Pty Ltd Methods for the preparation of biologically active compounds in nanoparticulate form
WO2008118331A2 (en) * 2007-03-22 2008-10-02 Schering Corporation Tablet formulations containing 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one salts and tablets made therefrom

Also Published As

Publication number Publication date
HK1256618A1 (en) 2019-09-27
HK1225958A1 (en) 2017-09-22

Similar Documents

Publication Publication Date Title
MY159098A (en) Production of encapsulated nanoparticles at high volume fractions
PH12015501780A1 (en) Production of encapsulated nanoparticles at commercial scale
PH12015501782A1 (en) Method for production of commercial nanoparticles and microparticle powders
PH12015500301A1 (en) A novel formulation of diclofenac
PH12016500746A1 (en) A novel formulation of meloxicam
TN2011000544A1 (en) A novel formualtion of indomethacin
TN2011000536A1 (en) A novel formulation of naproxen
MX2011011233A (en) A novel formulation of metaxalone.
PH12015501811A1 (en) Production of encapsulated nanoparticles at high volume fractions
NZ710321A (en) Production of encapsulated nanoparticles at high volume fractions
AU2014208310B2 (en) A Novel Formulation of Diclofenac
TH125552B (en) Production of nanoparticles trapped at high volumetric ratios